Brief: Mei Pharma Board Of Directors Rejects Unsolicited Proposal
U.S. STOCKS ON THE MOVE-Centerra Gold, gold miners, Travere Therapeutics
U.S. STOCKS ON THE MOVE-VerifyMe, Intel, Hewlett Packard Enterprise
MEI Pharma gains on buyout bid from Anson Funds-led group
U.S. STOCKS ON THE MOVE-Nvidia, Trevena, Akili
MEI Pharma rises on buyout bid from Anson Funds-led group
MEI Pharma gains on unsolicited buyout bid from Anson Funds
Brief: MEI Pharma Confirms Receipt Of Unsolicited Acquisition Proposal
Brief: Anson Funds Management Delivers Letter To Chairman Of MEI Pharma
Brief: MEI Pharma Announces Update Of Ongoing Phase 1 Study Evaluating Oral CDK9 Inhibitor Voruciclib Alone And In Combination With Venetoclax In Patients With Acute Myeloid Leukemia Or B-Cell Malignancies
Brief: Mei Pharma Reports Third Quarter Fiscal Year 2023 Results And Operational Highlights
Brief: MEI Pharma Announces 1-For-20 Reverse Stock Split
Brief: Mei Pharma Says Does Not Hold Any Deposits Or Securities Or Maintain Any Accounts At SVB
Brief: Mei Pharma And Infinity Pharmaceuticals Announce Definitive Merger Agreement
MEI Pharma Inc reports results for the quarter ended in December - Earnings Summary
Brief: MEI Pharma Reports Second Quarter Fiscal Year 2023 Results
MEI Pharma Inc expected to post a loss of 15 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Armstrong World Industries, Eli Lilly, Netflix
Brief: MEI Pharma Announces Adjournment Of Annual Meeting Of Stockholders